Customer Publication

Reversal of Chemoresistance in Ovarian Cancer by Co-delivery of a p-glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform

Authors: Yilin Zhang, Shravan Kumar Sriraman, Hilary A. Kenny, Ed Luther;Vladimir Torchilin, Ernst Lengyel

Journal: Molecular Cancer Therapeutics (2016)

Institution: University of Chicago

Research Areas: Cancer research

Cell Lines: SKOV 3 TR cells (Ovarian cancer cell line)

Summary: The authors created a nanoparticle formulation against chemotherapy resistant ovarian cancer, loaded with the commonly used cancer drug paclitaxel together with a drug that breaks down the resistance mechanism of cancer cells. Using HoloMonitor, the scientists were able to show that paclitaxel-resistant ovarian cancer cells stopped multiplying when treated with the nanoparticles.

Keywords: HoloMonitor M4, Cell cycle arrest, Apoptosis, Ovarian cancer

Read the article …